648 related articles for article (PubMed ID: 28739116)
1. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
[TBL] [Abstract][Full Text] [Related]
2. Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
Vaccine; 2016 Aug; 34(36):4313-20. PubMed ID: 27422342
[TBL] [Abstract][Full Text] [Related]
3. A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.
Dagan R; Ben-Shimol S; Simell B; Greenberg D; Porat N; Käyhty H; Givon-Lavi N
Vaccine; 2018 May; 36(20):2774-2782. PubMed ID: 29655626
[TBL] [Abstract][Full Text] [Related]
4. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
[TBL] [Abstract][Full Text] [Related]
6. Serotype-Specific Correlates of Protection for Pneumococcal Carriage: An Analysis of Immunity in 19 Countries.
Voysey M; Fanshawe TR; Kelly DF; O'Brien KL; Kandasamy R; Shrestha S; Thorson S; Hinds J; Pollard AJ
Clin Infect Dis; 2018 Mar; 66(6):913-920. PubMed ID: 29069415
[TBL] [Abstract][Full Text] [Related]
7. No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.
Licciardi PV; Toh ZQ; Clutterbuck EA; Balloch A; Marimla RA; Tikkanen L; Lamb KE; Bright KJ; Rabuatoka U; Tikoduadua L; Boelsen LK; Dunne EM; Satzke C; Cheung YB; Pollard AJ; Russell FM; Mulholland EK
J Allergy Clin Immunol; 2016 Jun; 137(6):1772-1779.e11. PubMed ID: 26825000
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
[TBL] [Abstract][Full Text] [Related]
9. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
[TBL] [Abstract][Full Text] [Related]
10. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
Dagan R
Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
[No Abstract] [Full Text] [Related]
11. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.
Le Polain De Waroux O; Flasche S; Prieto-Merino D; Goldblatt D; Edmunds WJ
Pediatr Infect Dis J; 2015 Aug; 34(8):858-64. PubMed ID: 26075814
[TBL] [Abstract][Full Text] [Related]
15. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
16. Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage.
Licciardi PV; Russell FM; Balloch A; Burton RL; Nahm MH; Gilbert G; Tang ML; Mulholland EK
Vaccine; 2014 Apr; 32(20):2321-7. PubMed ID: 24613524
[TBL] [Abstract][Full Text] [Related]
17. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
Akinsola AK; Ota MO; Enwere GC; Okoko BJ; Zaman SM; Saaka M; Nsekpong ED; Odutola AA; Greenwood BM; Cutts FT; Adegbola RA
PLoS One; 2012; 7(2):e31050. PubMed ID: 22363544
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
[TBL] [Abstract][Full Text] [Related]
20. Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.
Simell B; Nurkka A; Lahdenkari M; Givon-Lavi N; Käyhty H; Dagan R; Jokinen J
Clin Vaccine Immunol; 2012 Jan; 19(1):96-9. PubMed ID: 22072724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
